FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Frontiers in veterinary science2023; 10; 1125695; doi: 10.3389/fvets.2023.1125695

Systematic review and meta-analysis of positive long-term effects after intra-articular administration of orthobiologic therapeutics in horses with naturally occurring osteoarthritis.

Abstract: Equine veterinarians face challenges in treating horses with osteoarthritic joint pain in routine veterinary practice. All common treatment options aim to reduce the clinical consequences of osteoarthritis (OA) characterized by persistent synovitis and progressive degradation of articular cartilage. A range of joint-associated cell types and extracellular matrices are involved in the not yet entirely understood chronic inflammatory process. Regeneration of articular tissues to re-establish joint hemostasis is the future perspective when fundamental healing of OA is the long-term goal. The use of intra-articular applied biologic therapeutics derived from blood or mesenchymal stroma cell (MSC) sources is nowadays a well-accepted treatment option. Although this group of therapeutics is not totally consistent due to the lack of clear definitions and compositions, they all share a potential regenerative effect on articular tissues as described in and studies. However, the current stage of science in regenerative medicine needs to be supported by clinical reports as in fact, studies as well as studies using induced OA models still represent a fragment of the complex pathomechanism of naturally occurring OA. This systemic review aims to determine the long-term effect of orthobiologic therapeutics in horses suffering naturally occurring OA. Thereby, a meta-analysis of randomized controlled trials (RCTs) is conducted to describe the efficiency and safety of intra-articular applied orthobiologics in terms of lameness reduction in the long-term. Using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines, thirteen studies met the inclusion criteria for the systemic review. Four of those studies have further been evaluated by the meta-analysis comparing the long-term effect in lameness reduction. Each study was examined for risk of bias. For data evaluation, a random-effects model was used, describing the overall outcome in a forest plot. The I statistic was used to assess heterogeneity. Results indicate, that orthobiologic therapies represent an effective long-term and safe OA treatment option. Due to the inhomogeneity of included studies, no statements are provided addressing specific orthobiologic therapies, affected joints, OA stage and horse's intended use. Future clinical trials should follow standardized study designs to provide comparable data.
Copyright © 2023 Mayet, Zablotski, Roth, Brehm and Troillet.
Get Full Text
Publication Date: 2023-02-23 PubMed ID: 36908512PubMed Central: PMC9997849DOI: 10.3389/fvets.2023.1125695Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This scientific study reviews and analyzes the long-term benefits of intra-articular administration of orthobiologic therapeutics in horses with naturally occurring osteoarthritis, suggesting these therapies are a safe and effective treatment option.

Understanding Osteoarthritis in Horses and Treatment Challenges

  • The research was guided by the challenges equine vets face in managing joint pain caused by osteoarthritis, characterized by ongoing inflammation and progressive degradation of cartilage within the joint.
  • Various cell types and extracellular matrices involved in this chronic inflammatory process are not completely understood.

Intra-Articular Orthobiologic Therapeutics as Potential Solutions

  • The goal is to regenerate articular tissues, achieve joint homeostasis and therefore bring about core healing of osteoarthritis in the long run.
  • The research focuses on biologic therapeutics from blood or mesenchymal stroma cell sources, which are injected into the joint. Despite certain inconsistencies, these therapeutics all offer promising regenerative effects on cartilage as shown in lab and animal studies.

Review and Meta-Analysis Approach

  • The researchers aimed to understand the long-term impact of these orthobiologic therapeutics on horses with naturally occurring osteoarthritis.
  • A systematic review and meta-analysis of Randomized Controlled Trials (RCTs) were used to understand the efficacy and safety of these therapeutics in reducing lameness over the long term.
  • Thirteen studies met the criteria for inclusion in the review, with four of those further analyzed in the meta-analysis.
  • A random-effects model was used for data evaluation and the I statistic was used to assess heterogeneity among carefully selected studies.

Findings and Further Research Recommendations

  • The research suggests that orthobiologic therapies are a safe and effective long-term treatment option. However, a wide range of differences among the reviewed studies meant that no specific conclusions were drawn about particular orthobiologic therapies, the stage of osteoarthritis, affected joints or the horse’s intended use.
  • The study calls for more clinical trials with standardized designs to offer comparative data and provide a more comprehensive understanding of the effectiveness of these therapies.

Cite This Article

APA
Mayet A, Zablotski Y, Roth SP, Brehm W, Troillet A. (2023). Systematic review and meta-analysis of positive long-term effects after intra-articular administration of orthobiologic therapeutics in horses with naturally occurring osteoarthritis. Front Vet Sci, 10, 1125695. https://doi.org/10.3389/fvets.2023.1125695

Publication

Frontiers in veterinary science
ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 10
Pages: 1125695
PII: 1125695

Researcher Affiliations

Mayet, Anna
  • Department for Horses, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany.
Zablotski, Yury
  • Center for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, Ludwig-Maximilians-University, Munich, Germany.
Roth, Susanne Pauline
  • Department for Horses, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany.
Brehm, Walter
  • Department for Horses, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany.
Troillet, Antonia
  • Department for Horses, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 112 references
  1. Kuyinu EL, Narayanan G, Nair LS, Laurencin CT. Animal models of osteoarthritis: classification, update, and measurement of outcomes.. J Orthop Surg Res 2016 Feb 2;11:19.
    doi: 10.1186/s13018-016-0346-5pmc: PMC4738796pubmed: 26837951google scholar: lookup
  2. McCoy AM. Animal Models of Osteoarthritis: Comparisons and Key Considerations.. Vet Pathol 2015 Sep;52(5):803-18.
    doi: 10.1177/0300985815588611pubmed: 26063173google scholar: lookup
  3. Roseti L, Desando G, Cavallo C, Petretta M, Grigolo B. Articular Cartilage Regeneration in Osteoarthritis.. Cells 2019 Oct 23;8(11).
    doi: 10.3390/cells8111305pmc: PMC6912428pubmed: 31652798google scholar: lookup
  4. Estrada McDermott J, Pezzanite L, Goodrich L, Santangelo K, Chow L, Dow S, Wheat W. Role of Innate Immunity in Initiation and Progression of Osteoarthritis, with Emphasis on Horses.. Animals (Basel) 2021 Nov 13;11(11).
    doi: 10.3390/ani11113247pmc: PMC8614551pubmed: 34827979google scholar: lookup
  5. Caron JP, Genovese RL. Principles and Practices of Joint Disease Treatment. In:M. Ross, S. Dyson, editors. Diagnosis and Management of Lameness in the Horse. Philadelphia: W.B. Saunders; (2003) 746–64.
    doi: 10.1016/B978-0-7216-8342-3.50092-9google scholar: lookup
  6. Mahmoud EE, Hassaneen ASA, Noby MA, Mawas AS, Abdel-Hady ANA. Equine osteoarthritis: an overview of different treatment strategies. SVU Int J Vet Sci (2021) 4:85–96.
    doi: 10.21608/svu.2021.57242.1099google scholar: lookup
  7. van Weeren PR, Back W. Musculoskeletal Disease in Aged Horses and Its Management.. Vet Clin North Am Equine Pract 2016 Aug;32(2):229-47.
    doi: 10.1016/j.cveq.2016.04.003pubmed: 27449390google scholar: lookup
  8. Morris EA, Seeherman HJ. Clinical evaluation of poor performance in the racehorse: the results of 275 evaluations.. Equine Vet J 1991 May;23(3):169-74.
    doi: 10.1111/j.2042-3306.1991.tb02749.xpubmed: 1884697google scholar: lookup
  9. Niemelä TM, Tulamo RM, Hielm-Björkman AK. A randomised, double-blinded, placebo-controlled clinical study on intra-articular hyaluronan treatment in equine lameness originating from the metacarpophalangeal joint.. BMC Vet Res 2016 Mar 23;12:60.
    doi: 10.1186/s12917-016-0687-7pmc: PMC4804525pubmed: 27005478google scholar: lookup
  10. Neundorf RH, Lowerison MB, Cruz AM, Thomason JJ, McEwen BJ, Hurtig MB. Determination of the prevalence and severity of metacarpophalangeal joint osteoarthritis in Thoroughbred racehorses via quantitative macroscopic evaluation.. Am J Vet Res 2010 Nov;71(11):1284-93.
    doi: 10.2460/ajvr.71.11.1284pubmed: 21034319google scholar: lookup
  11. Bertuglia A, Pagliara E, Grego E, Ricci A, Brkljaca-Bottegaro N. Pro-inflammatory cytokines and structural biomarkers are effective to categorize osteoarthritis phenotype and progression in Standardbred racehorses over five years of racing career.. BMC Vet Res 2016 Nov 8;12(1):246.
    doi: 10.1186/s12917-016-0873-7pmc: PMC5100096pubmed: 27821120google scholar: lookup
  12. Auer JA, Fackelmann GE. Treatment of degenerative joint disease of the horse: a review and commentary. Vet Surg (1981) 10:80–9.
    doi: 10.1111/j.1532-950X.1981.tb00635.xpubmed: 0google scholar: lookup
  13. Yamada ALM, Pinheiro M, Marsiglia MF, Hagen SCF, Baccarin RYA, da Silva LCLC. Ultrasound and clinical findings in the metacarpophalangeal joint assessment of show jumping horses in training.. J Vet Sci 2020 May;21(3):e21.
    doi: 10.4142/jvs.2020.21.e21pmc: PMC7263911pubmed: 32476309google scholar: lookup
  14. Baccarin RYA, Seidel SRT, Michelacci YM, Tokawa PKA, Oliveira TM. Osteoarthritis: a common disease that should be avoided in the athletic horse's life.. Anim Front 2022 Jun;12(3):25-36.
    doi: 10.1093/af/vfac026pmc: PMC9197312pubmed: 35711506google scholar: lookup
  15. McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis.. Bone Joint Res 2012 Nov;1(11):297-309.
    doi: 10.1302/2046-3758.111.2000132pmc: PMC3626203pubmed: 23610661google scholar: lookup
  16. Cantley CE, Firth EC, Delahunt JW, Pfeiffer DU, Thompson KG. Naturally occurring osteoarthritis in the metacarpophalangeal joints of wild horses.. Equine Vet J 1999 Jan;31(1):73-81.
    doi: 10.1111/j.2042-3306.1999.tb03794.xpubmed: 9952333google scholar: lookup
  17. Panizzi L, Barber SM, Lang HM, Carmalt JL. Carpometacarpal osteoarthritis in thirty-three horses.. Vet Surg 2009 Dec;38(8):998-1005.
    doi: 10.1111/j.1532-950X.2009.00589.xpubmed: 20017859google scholar: lookup
  18. Ferris DJ, Frisbie DD, Kisiday JD, McIlwraith CW, Hague BA, Major MD, Schneider RK, Zubrod CJ, Kawcak CE, Goodrich LR. Clinical outcome after intra-articular administration of bone marrow derived mesenchymal stem cells in 33 horses with stifle injury.. Vet Surg 2014 Mar;43(3):255-65.
    doi: 10.1111/j.1532-950X.2014.12100.xpubmed: 24433318google scholar: lookup
  19. Smit Y, Marais HJ, Thompson PN, Mahne AT, Goddard A. Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis.. J S Afr Vet Assoc 2019 May 23;90(0):e1-e9.
    doi: 10.4102/jsava.v90i0.1721pmc: PMC6556911pubmed: 31170778google scholar: lookup
  20. McIlwraith CW, Frisbie DD, Kawcak CE, Fuller CJ, Hurtig M, Cruz A. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the horse.. Osteoarthritis Cartilage 2010 Oct;18 Suppl 3:S93-105.
    doi: 10.1016/j.joca.2010.05.031pubmed: 20864027google scholar: lookup
  21. Goodrich LR, Nixon AJ. Medical treatment of osteoarthritis in the horse - a review.. Vet J 2006 Jan;171(1):51-69.
    doi: 10.1016/j.tvjl.2004.07.008pubmed: 16427582google scholar: lookup
  22. Contino EK. Management and Rehabilitation of Joint Disease in Sport Horses.. Vet Clin North Am Equine Pract 2018 Aug;34(2):345-358.
    doi: 10.1016/j.cveq.2018.04.007pubmed: 29793734google scholar: lookup
  23. Carmona JU, Ríos DL, López C, Álvarez ME, Pérez JE, Bohórquez ME. In vitro effects of platelet-rich gel supernatants on histology and chondrocyte apoptosis scores, hyaluronan release and gene expression of equine cartilage explants challenged with lipopolysaccharide.. BMC Vet Res 2016 Jul 1;12(1):135.
    doi: 10.1186/s12917-016-0759-8pmc: PMC4929746pubmed: 27369779google scholar: lookup
  24. Colbath AC, Dow SW, Phillips JN, McIlwraith CW, Goodrich LR. Autologous and Allogeneic Equine Mesenchymal Stem Cells Exhibit Equivalent Immunomodulatory Properties In Vitro.. Stem Cells Dev 2017 Apr 1;26(7):503-511.
    doi: 10.1089/scd.2016.0266pubmed: 27958776google scholar: lookup
  25. Blázquez R, Sánchez-Margallo FM, Reinecke J, Álvarez V, López E, Marinaro F, Casado JG. Conditioned Serum Enhances the Chondrogenic and Immunomodulatory Behavior of Mesenchymal Stem Cells.. Front Pharmacol 2019;10:699.
    doi: 10.3389/fphar.2019.00699pmc: PMC6609570pubmed: 31316380google scholar: lookup
  26. Hraha TH, Doremus KM, McIlwraith CW, Frisbie DD. Autologous conditioned serum: the comparative cytokine profiles of two commercial methods (IRAP and IRAP II) using equine blood.. Equine Vet J 2011 Sep;43(5):516-21.
    doi: 10.1111/j.2042-3306.2010.00321.xpubmed: 21496084google scholar: lookup
  27. Yamada ALM, Carvalho A de M, Moroz A, Deffune E, Watanabe MJ, Hussni CA. Mesenchymal stem cell enhances chondral defects healing in horses. Stem Cell Discov (2013) 03:218–25.
    doi: 10.4236/scd.2013.34027google scholar: lookup
  28. Frisbie DD, Kawcak CE, McIlwraith CW. 520 evaluation of autologous conditioned serum using an experimental model of equine osteoarthritis. Osteoarthr Cartil (2008) 16:S222–3.
    doi: 10.1016/S1063-4584(08)60559-2google scholar: lookup
  29. McIlwraith CW, Frisbie DD, Rodkey WG, Kisiday JD, Werpy NM, Kawcak CE, Steadman JR. Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects.. Arthroscopy 2011 Nov;27(11):1552-61.
    doi: 10.1016/j.arthro.2011.06.002pubmed: 21862278google scholar: lookup
  30. Frisbie DD, Kawcak CE, Werpy NM, Park RD, McIlwraith CW. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis.. Am J Vet Res 2007 Mar;68(3):290-6.
    doi: 10.2460/ajvr.68.3.290pubmed: 17331019google scholar: lookup
  31. Magri C, Schramme M, Febre M, Cauvin E, Labadie F, Saulnier N, François I, Lechartier A, Aebischer D, Moncelet AS, Maddens S. Comparison of efficacy and safety of single versus repeated intra-articular injection of allogeneic neonatal mesenchymal stem cells for treatment of osteoarthritis of the metacarpophalangeal/metatarsophalangeal joint in horses: A clinical pilot study.. PLoS One 2019;14(8):e0221317.
    doi: 10.1371/journal.pone.0221317pmc: PMC6715221pubmed: 31465445google scholar: lookup
  32. Carmona JU, Argüelles D, Climent F, Prades M. Autologous platelet concentrates as a treatment of horses with osteoarthritis: a preliminary pilot clinical study. J Equine Vet Sci (2007) 27:167–70.
    doi: 10.1016/j.jevs.2007.02.007google scholar: lookup
  33. Camargo Garbin L, Morris MJ. A Comparative Review of Autologous Conditioned Serum and Autologous Protein Solution for Treatment of Osteoarthritis in Horses.. Front Vet Sci 2021;8:602978.
    doi: 10.3389/fvets.2021.602978pmc: PMC7933025pubmed: 33681323google scholar: lookup
  34. Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T, Kaneda Y. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy.. J Atheroscler Thromb 2006 Apr;13(2):77-81.
    doi: 10.5551/jat.13.77pubmed: 16733294google scholar: lookup
  35. Roth SP, Burk J, Brehm W, Troillet A. MSC in Tendon and Joint Disease: The Context-Sensitive Link Between Targets and Therapeutic Mechanisms.. Front Bioeng Biotechnol 2022;10:855095.
    doi: 10.3389/fbioe.2022.855095pmc: PMC9015188pubmed: 35445006google scholar: lookup
  36. Aldrich ED, Cui X, Murphy CA, Lim KS, Hooper GJ, McIlwraith CW, Woodfield TBF. Allogeneic mesenchymal stromal cells for cartilage regeneration: A review of in vitro evaluation, clinical experience, and translational opportunities.. Stem Cells Transl Med 2021 Nov;10(11):1500-1515.
    doi: 10.1002/sctm.20-0552pmc: PMC8550704pubmed: 34387402google scholar: lookup
  37. Yin Z, Yang X, Jiang Y, Xing L, Xu Y, Lu Y, Ding P, Ma J, Xu Y, Gui J. Platelet-rich plasma combined with agarose as a bioactive scaffold to enhance cartilage repair: an in vitro study.. J Biomater Appl 2014 Mar;28(7):1039-50.
    doi: 10.1177/0885328213492573pubmed: 23828781google scholar: lookup
  38. Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a caprine model of osteoarthritis.. Arthritis Rheum 2003 Dec;48(12):3464-74.
    doi: 10.1002/art.11365pubmed: 14673997google scholar: lookup
  39. Kriston-Pál É, Haracska L, Cooper P, Kiss-Tóth E, Szukacsov V, Monostori É. A Regenerative Approach to Canine Osteoarthritis Using Allogeneic, Adipose-Derived Mesenchymal Stem Cells. Safety Results of a Long-Term Follow-Up.. Front Vet Sci 2020;7:510.
    doi: 10.3389/fvets.2020.00510pmc: PMC7438407pubmed: 32903517google scholar: lookup
  40. Broeckx S, Suls M, Beerts C, Vandenberghe A, Seys B, Wuertz-Kozak K, Duchateau L, Spaas JH. Allogenic mesenchymal stem cells as a treatment for equine degenerative joint disease: a pilot study.. Curr Stem Cell Res Ther 2014;9(6):497-503.
    doi: 10.2174/1574888X09666140826110601pubmed: 25175766google scholar: lookup
  41. Roth SP, Brehm W, Troillet A. [Cell-based therapeutic strategies for osteoarthritis in equine patients - Basic knowledge for clinical practitioners].. Tierarztl Prax Ausg G Grosstiere Nutztiere 2021 Jun;49(3):189-202.
    doi: 10.1055/a-1482-7752pubmed: 34157748google scholar: lookup
  42. Bogers SH. Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know.. Front Vet Sci 2018;5:70.
    doi: 10.3389/fvets.2018.00070pmc: PMC5911772pubmed: 29713634google scholar: lookup
  43. Voga M, Adamic N, Vengust M, Majdic G. Stem Cells in Veterinary Medicine-Current State and Treatment Options.. Front Vet Sci 2020;7:278.
    doi: 10.3389/fvets.2020.00278pmc: PMC7326035pubmed: 32656249google scholar: lookup
  44. Maniar HH, Tawari AA, Suk M, Horwitz DS. The Current Role of Stem Cells in Orthopaedic Surgery.. Malays Orthop J 2015 Nov;9(3):1-7.
    doi: 10.5704/MOJ.1511.016pmc: PMC5393127pubmed: 28611902google scholar: lookup
  45. Capparè P, Tetè G, Sberna MT, Panina-Bordignon P. The Emerging Role of Stem Cells in Regenerative Dentistry.. Curr Gene Ther 2020;20(4):259-268.
    doi: 10.2174/1566523220999200818115803pubmed: 32811413google scholar: lookup
  46. Mokbel AN, El Tookhy OS, Shamaa AA, Rashed LA, Sabry D, El Sayed AM. Homing and reparative effect of intra-articular injection of autologus mesenchymal stem cells in osteoarthritic animal model.. BMC Musculoskelet Disord 2011 Nov 15;12:259.
    doi: 10.1186/1471-2474-12-259pmc: PMC3232438pubmed: 22085445google scholar: lookup
  47. Fisher SA, Brunskill SJ, Doree C, Mathur A, Taggart DP, Martin-Rendon E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.. Cochrane Database Syst Rev 2014 Apr 29;(4):CD007888.
    doi: 10.1002/14651858.CD007888.pub2pubmed: 24777540google scholar: lookup
  48. Aligholi H, Safahani M, Asadi-Pooya AA. Stem cell therapy in patients with epilepsy: A systematic review.. Clin Neurol Neurosurg 2021 Jan;200:106416.
    doi: 10.1016/j.clineuro.2020.106416pubmed: 33338823google scholar: lookup
  49. MacDonald ES, Barrett JG. The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses.. Front Vet Sci 2019;6:507.
    doi: 10.3389/fvets.2019.00507pmc: PMC6985200pubmed: 32039250google scholar: lookup
  50. Zhu C, Wu W, Qu X. Mesenchymal stem cells in osteoarthritis therapy: a review.. Am J Transl Res 2021;13(2):448-461.
    pmc: PMC7868850pubmed: 33594303
  51. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.. Cytotherapy 2005;7(5):393-5.
    doi: 10.1080/14653240500319234pubmed: 16236628google scholar: lookup
  52. Caplan AI, Correa D. The MSC: an injury drugstore.. Cell Stem Cell 2011 Jul 8;9(1):11-5.
    doi: 10.1016/j.stem.2011.06.008pmc: PMC3144500pubmed: 21726829google scholar: lookup
  53. Caplan AI. Mesenchymal Stem Cells: Time to Change the Name!. Stem Cells Transl Med 2017 Jun;6(6):1445-1451.
    doi: 10.1002/sctm.17-0051pmc: PMC5689741pubmed: 28452204google scholar: lookup
  54. Lawver J, Thaler R. Ultrasound-guided lipoaspiration for mesenchymal stromal cell harvest in the horse. Equine Vet Educ (2016) 28:23–9.
    doi: 10.1111/eve.12398google scholar: lookup
  55. Mariñas-Pardo L, García-Castro J, Rodríguez-Hurtado I, Rodríguez-García MI, Núñez-Naveira L, Hermida-Prieto M. Allogeneic Adipose-Derived Mesenchymal Stem Cells (Horse Allo 20) for the Treatment of Osteoarthritis-Associated Lameness in Horses: Characterization, Safety, and Efficacy of Intra-Articular Treatment.. Stem Cells Dev 2018 Sep 1;27(17):1147-1160.
    doi: 10.1089/scd.2018.0074pubmed: 29978736google scholar: lookup
  56. Brehm W, Burk J, Delling U, Gittel C, Ribitsch I. Stem cell-based tissue engineering in veterinary orthopaedics.. Cell Tissue Res 2012 Mar;347(3):677-688.
    doi: 10.1007/s00441-011-1316-1pubmed: 22287044google scholar: lookup
  57. Broeckx SY, Martens AM, Bertone AL, Van Brantegem L, Duchateau L, Van Hecke L, Dumoulin M, Oosterlinck M, Chiers K, Hussein H, Pille F, Spaas JH. The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study.. Equine Vet J 2019 Nov;51(6):787-794.
    doi: 10.1111/evj.13089pmc: PMC6850029pubmed: 30815897google scholar: lookup
  58. Broeckx SY, Spaas JH, Chiers K, Duchateau L, Van Hecke L, Van Brantegem L, Dumoulin M, Martens AM, Pille F. Equine allogeneic chondrogenic induced mesenchymal stem cells: A GCP target animal safety and biodistribution study.. Res Vet Sci 2018 Apr;117:246-254.
    doi: 10.1016/j.rvsc.2017.12.018pubmed: 29329028google scholar: lookup
  59. . Arti-Cell Forte (Chondrogenic Induced Equine Allogeneic Peripheral Blood-Derived Mesenchymal Stem Cells). (2018).
  60. . HorStem (Equine Umbilical Cord Mesenchymal Stem Cells) What is HorStem and what is it used for? How is HorStem used? How does HorStem work?. (2019).
  61. Pradera Muñoz A. Efficacy and safety study of allogeneic Equine Umbilical Cord derived Mesenchymal Stem Cells (EUC-MSCs) for the treatment of clinical symptomatology associated with mild to moderate degenerative joint disease (osteoarthritis) in horses under field conditions. (Dissertation). Madrid, Spain, Universidad Autónoma de Madrid. (2019).
  62. Schnabel LV, Fortier LA, McIlwraith CW, Nobert KM. Therapeutic use of stem cells in horses: which type, how, and when?. Vet J 2013 Sep;197(3):570-7.
    doi: 10.1016/j.tvjl.2013.04.018pubmed: 23778257google scholar: lookup
  63. Bruno I, Martinez R, Sanchez A, Friddle C, McClure SR. Characterization of nucleated cells from equine adipose tissue and bone marrow aspirate processed for point-of-care use. J Equine Vet Sci (2014) 34:1118–27.
    doi: 10.1016/j.jevs.2014.06.023google scholar: lookup
  64. Taylor SE, Clegg PD. Collection and propagation methods for mesenchymal stromal cells.. Vet Clin North Am Equine Pract 2011 Aug;27(2):263-74.
    doi: 10.1016/j.cveq.2011.05.003pubmed: 21872758google scholar: lookup
  65. Koch TG, Thomsen PD, Betts DH. Improved isolation protocol for equine cord blood-derived mesenchymal stromal cells.. Cytotherapy 2009;11(4):443-7.
    doi: 10.1080/14653240902887259pubmed: 19513899google scholar: lookup
  66. Bourzac C, Smith LC, Vincent P, Beauchamp G, Lavoie JP, Laverty S. Isolation of equine bone marrow-derived mesenchymal stem cells: a comparison between three protocols.. Equine Vet J 2010 Sep;42(6):519-27.
    doi: 10.1111/j.2042-3306.2010.00098.xpubmed: 20716192google scholar: lookup
  67. Ionita CR, Troillet AR, Vahlenkamp TW, Winter K, Brehm W, Ionita JC. Comparison of humoral insulin-like growth factor-1, platelet-derived growth factor-BB, transforming growth factor-β1, and interleukin-1 receptor antagonist concentrations among equine autologous blood-derived preparations.. Am J Vet Res 2016 Aug;77(8):898-905.
    doi: 10.2460/ajvr.77.8.898pubmed: 27463555google scholar: lookup
  68. Hessel LN, Bosch G, van Weeren PR, Ionita JC. Equine autologous platelet concentrates: A comparative study between different available systems.. Equine Vet J 2015 May;47(3):319-25.
    doi: 10.1111/evj.12288pubmed: 24773596google scholar: lookup
  69. Textor J. Autologous biologic treatment for equine musculoskeletal injuries: platelet-rich plasma and IL-1 receptor antagonist protein.. Vet Clin North Am Equine Pract 2011 Aug;27(2):275-98.
    doi: 10.1016/j.cveq.2011.05.001pubmed: 21872759google scholar: lookup
  70. Brossi PM, Moreira JJ, Machado TS, Baccarin RY. Platelet-rich plasma in orthopedic therapy: a comparative systematic review of clinical and experimental data in equine and human musculoskeletal lesions.. BMC Vet Res 2015 Apr 22;11:98.
    doi: 10.1186/s12917-015-0403-zpmc: PMC4449579pubmed: 25896610google scholar: lookup
  71. Lee EB, Kim JW, Seo JP. Comparison of the methods for platelet rich plasma preparation in horses.. J Anim Sci Technol 2018;60:20.
    doi: 10.1186/s40781-018-0178-4pmc: PMC6098823pubmed: 30147942google scholar: lookup
  72. Textor JA, Willits NH, Tablin F. Synovial fluid growth factor and cytokine concentrations after intra-articular injection of a platelet-rich product in horses.. Vet J 2013 Oct;198(1):217-23.
    doi: 10.1016/j.tvjl.2013.07.020pubmed: 23992870google scholar: lookup
  73. Agrawal AA. Evolution, current status and advances in application of platelet concentrate in periodontics and implantology.. World J Clin Cases 2017 May 16;5(5):159-171.
    doi: 10.12998/wjcc.v5.i5.159pmc: PMC5434315pubmed: 28560233google scholar: lookup
  74. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent 2001;10(4):225-8.
    doi: 10.1097/00008505-200110000-00002pubmed: 11813662google scholar: lookup
  75. Bertone AL, Ishihara A, Zekas LJ, Wellman ML, Lewis KB, Schwarze RA, Barnaba AR, Schmall ML, Kanter PM, Genovese RL. Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses.. Am J Vet Res 2014 Feb;75(2):141-51.
    doi: 10.2460/ajvr.75.2.141pubmed: 24471750google scholar: lookup
  76. Velloso Alvarez A, Boone LH, Braim AP, Taintor JS, Caldwell F, Wright JC, Wooldridge AA. A Survey of Clinical Usage of Non-steroidal Intra-Articular Therapeutics by Equine Practitioners.. Front Vet Sci 2020;7:579967.
    doi: 10.3389/fvets.2020.579967pmc: PMC7642446pubmed: 33195592google scholar: lookup
  77. Broeckx S, Zimmerman M, Crocetti S, Suls M, Mariën T, Ferguson SJ, Chiers K, Duchateau L, Franco-Obregón A, Wuertz K, Spaas JH. Regenerative therapies for equine degenerative joint disease: a preliminary study.. PLoS One 2014;9(1):e85917.
    doi: 10.1371/journal.pone.0085917pmc: PMC3896436pubmed: 24465787google scholar: lookup
  78. Geburek F, Lietzau M, Beineke A, Rohn K, Stadler PM. Effect of a single injection of autologous conditioned serum (ACS) on tendon healing in equine naturally occurring tendinopathies.. Stem Cell Res Ther 2015 Jun 26;6(1):126.
    doi: 10.1186/s13287-015-0115-0pmc: PMC4513386pubmed: 26113022google scholar: lookup
  79. Meijer H, Reinecke J, Becker C, Tholen G, Wehling P. The production of anti-inflammatory cytokines in whole blood by physico-chemical induction.. Inflamm Res 2003 Oct;52(10):404-7.
    doi: 10.1007/s00011-003-1197-1pubmed: 14520515google scholar: lookup
  80. Wehling P, Moser C, Frisbie D, McIlwraith CW, Kawcak CE, Krauspe R, Reinecke JA. Autologous conditioned serum in the treatment of orthopedic diseases: the orthokine therapy.. BioDrugs 2007;21(5):323-32.
    doi: 10.2165/00063030-200721050-00004pubmed: 17896838google scholar: lookup
  81. Marques-Smith P, Kallerud AS, Johansen GM, Boysen P, Jacobsen AM, Reitan KM, Henriksen MM, Löfgren M, Fjordbakk CT. Is clinical effect of autologous conditioned serum in spontaneously occurring equine articular lameness related to ACS cytokine profile?. BMC Vet Res 2020 Jun 8;16(1):181.
    doi: 10.1186/s12917-020-02391-7pmc: PMC7278142pubmed: 32513154google scholar: lookup
  82. Frisbie DD, Ghivizzani SC, Robbins PD, Evans CH, McIlwraith CW. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene.. Gene Ther 2002 Jan;9(1):12-20.
    doi: 10.1038/sj.gt.3301608pubmed: 11850718google scholar: lookup
  83. Lasarzik J, Bondzio A, Rettig M, Estrada R, Klaus C, Ehrle A. Evaluation of two protocols using autologous conditioned serum for intra-articular therapy of equine osteoarthritis—A pilot study monitoring cytokines and cartilage-specific biomarkers. J Equine Vet Sci (2018) 60:35–42.e2.
    doi: 10.1016/j.jevs.2016.09.014google scholar: lookup
  84. Ran J, Yang X, Ren Z, Wang J, Dong H. Comparison of intra-articular hyaluronic acid and methylprednisolone for pain management in knee osteoarthritis: A meta-analysis of randomized controlled trials.. Int J Surg 2018 May;53:103-110.
    doi: 10.1016/j.ijsu.2018.02.065pubmed: 29574247google scholar: lookup
  85. Doll S. Metaanalyse klinischer Studien 1983-2016 zur langfristigen Gebrauchsfähigkeit von Sportpferden nach Behandlung von natürlich entstandenen Erkrankungen der oberflächlichen und der tiefen Beugesehne und des Fesselträgers entweder allein mit kontrollierter Bewegung oder kombiniert mit einem potenziell regenerativen Therapeutikum. (Dissertation). Leipzig, Germany, Veterinärmedizinische Fakultät der Universität Leipzig. (2019).
  86. Broeckx SY, Seys B, Suls M, Vandenberghe A, Mariën T, Adriaensen E, Declercq J, Van Hecke L, Braun G, Hellmann K, Spaas JH. Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses.. Stem Cells Dev 2019 Mar 15;28(6):410-422.
    doi: 10.1089/scd.2018.0061pmc: PMC6441287pubmed: 30623737google scholar: lookup
  87. Fürst A, Veith G, Eisenreich J. A prospective comparison of the GOLDIC ® technique and corticosteroid plus hyaluronic acid injections for arthrogenic lameness in horses. Medicine (Baltimore) (2020) 36:196–204.
    doi: 10.21836/PEM20200301google scholar: lookup
  88. Warner K, Schulze T, Lischer CJ. Behandlung von osteoarthritis mit ACS (IRAP®) bei 26 pferden-retrospektive studie. Pferdeheilkunde (2016) 32:241–8.
    doi: 10.21836/PEM20160307google scholar: lookup
  89. Tyrnenopoulou P, Diakakis N, Karayannopoulou M, Savvas I, Koliakos G. Evaluation of intra-articular injection of autologous platelet lysate (PL) in horses with osteoarthritis of the distal interphalangeal joint.. Vet Q 2016 Jun;36(2):56-62.
    doi: 10.1080/01652176.2016.1141257pubmed: 26828234google scholar: lookup
  90. Bembo F, Eraud J, Philandrianos C, Bertrand B, Silvestre A, Veran J, Sabatier F, Magalon G, Magalon J. Combined use of platelet rich plasma & micro-fat in sport and race horses with degenerative joint disease: preliminary clinical study in eight horses.. Muscles Ligaments Tendons J 2016 Apr-Jun;6(2):198-204.
    doi: 10.11138/mltj/2016.6.2.198pmc: PMC5115251pubmed: 27900293google scholar: lookup
  91. Pichereau F, Décory M, Cuevas Ramos G. Autologous platelet concentrate as a treatment for horses with refractory fetlock osteoarthritis. J Equine Vet Sci (2014) 34:489–93.
    doi: 10.1016/j.jevs.2013.10.004google scholar: lookup
  92. Jöstingmeier U. Vergleichende Betrachtung des Behandlungserfolges der intraartikulären kombinierten Behandlung mit Natriumhyaluronat und Betamethason mit der intraartikulären Behandlung mit autologem konditionierten Serum (IL-1 Ra) bei Pferden mit positiver Hufgelenkanästhesie- Eine Anwendungsbeobachtung. (Dissertation). Berlin, Germany, Freie Universität Berlin. (2009).
  93. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.. PLoS Med 2009 Jul 21;6(7):e1000097.
    doi: 10.1371/journal.pmed.1000097pmc: PMC2707599pubmed: 19621072google scholar: lookup
  94. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.. BMJ 2011 Oct 18;343:d5928.
    doi: 10.1136/bmj.d5928pmc: PMC3196245pubmed: 22008217google scholar: lookup
  95. R Core Team. R: A Language Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. (2022).
  96. Lewis S, Clarke M. Forest plots: trying to see the wood and the trees.. BMJ 2001 Jun 16;322(7300):1479-80.
    doi: 10.1136/bmj.322.7300.1479pmc: PMC1120528pubmed: 11408310google scholar: lookup
  97. Dettori JR, Norvell DC, Chapman JR. Seeing the Forest by Looking at the Trees: How to Interpret a Meta-Analysis Forest Plot.. Global Spine J 2021 May;11(4):614-616.
    doi: 10.1177/21925682211003889pmc: PMC8119923pubmed: 33939533google scholar: lookup
  98. McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments.. Res Synth Methods 2021 Jan;12(1):55-61.
    doi: 10.1002/jrsm.1411pubmed: 32336025google scholar: lookup
  99. Barrachina L, Remacha AR, Romero A, Vitoria A, Albareda J, Prades M, Roca M, Zaragoza P, Vázquez FJ, Rodellar C. Assessment of effectiveness and safety of repeat administration of proinflammatory primed allogeneic mesenchymal stem cells in an equine model of chemically induced osteoarthritis.. BMC Vet Res 2018 Aug 17;14(1):241.
    doi: 10.1186/s12917-018-1556-3pmc: PMC6098603pubmed: 30119668google scholar: lookup
  100. Frisbie DD, Kawcak CE, Werpy NM, McIlwraith CW. 519 evaluation of bone marrow derived stem cells and adipose derived stromal vascular fraction for treatment of osteoarthritis using an equine experimental model. Osteoarthr Cartil (2008) 16:S222.
    doi: 10.1016/S1063-4584(08)60558-0google scholar: lookup
  101. Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM, McIlwraith CW. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis.. J Orthop Res 2009 Dec;27(12):1675-80.
    doi: 10.1002/jor.20933pubmed: 19544397google scholar: lookup
  102. Nicpoń J, Marycz K, Grzesiak J. Therapeutic effect of adipose-derived mesenchymal stem cell injection in horses suffering from bone spavin.. Pol J Vet Sci 2013;16(4):753-4.
    doi: 10.2478/pjvs-2013-0107pubmed: 24597313google scholar: lookup
  103. Abellanet I, Padres M. Intraarticular platelet rich plasma (PRP) therapy: Evaluation in 42 sport horse with OA. [Conference presentation]. In: Proceedings of the 11th International Congress of the World Equine Veterinary Association. Brazil. (2009).
  104. Mirza MH, Bommala P, Richbourg HA, Rademacher N, Kearney MT, Lopez MJ. Gait Changes Vary among Horses with Naturally Occurring Osteoarthritis Following Intra-articular Administration of Autologous Platelet-Rich Plasma.. Front Vet Sci 2016;3:29.
    doi: 10.3389/fvets.2016.00029pmc: PMC4829588pubmed: 27148544google scholar: lookup
  105. Weinberger T. Klinische Erfahrungen mit der Anwendung von ACS/ORTHOKIN/IRAP beim Pferd. Pferde Spiegel (2008) 11:111–4.
    doi: 10.1055/s-0029-1225792google scholar: lookup
  106. Rothstein HR, Bushman BJ. Publication bias in psychological science: comment on Ferguson and Brannick (2012).. Psychol Methods 2012 Mar;17(1):129-36.
    doi: 10.1037/a0027128pubmed: 22369520google scholar: lookup
  107. Anderson DD, Chubinskaya S, Guilak F, Martin JA, Oegema TR, Olson SA, Buckwalter JA. Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention.. J Orthop Res 2011 Jun;29(6):802-9.
    doi: 10.1002/jor.21359pmc: PMC3082940pubmed: 21520254google scholar: lookup
  108. Vitale ND, Vandenbulcke F, Chisari E, Iacono F, Lovato L, Di Matteo B, Kon E. Innovative regenerative medicine in the management of knee OA: The role of Autologous Protein Solution.. J Clin Orthop Trauma 2019 Jan-Feb;10(1):49-52.
    doi: 10.1016/j.jcot.2018.08.019pmc: PMC6349612pubmed: 30705532google scholar: lookup
  109. Liu TP, Ha P, Xiao CY, Kim SY, Jensen AR, Easley J, Yao Q, Zhang X. Updates on mesenchymal stem cell therapies for articular cartilage regeneration in large animal models.. Front Cell Dev Biol 2022;10:982199.
    doi: 10.3389/fcell.2022.982199pmc: PMC9485723pubmed: 36147737google scholar: lookup
  110. Montano C, Auletta L, Greco A, Costanza D, Coluccia P, Del Prete C, Meomartino L, Pasolini MP. The Use of Platelet-Rich Plasma for Treatment of Tenodesmic Lesions in Horses: A Systematic Review and Meta-Analysis of Clinical and Experimental Data.. Animals (Basel) 2021 Mar 12;11(3).
    doi: 10.3390/ani11030793pmc: PMC7998797pubmed: 33809227google scholar: lookup
  111. Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what.. Lancet 2002 Feb 23;359(9307):696-700.
    doi: 10.1016/S0140-6736(02)07816-9pubmed: 11879884google scholar: lookup
  112. Miller LE, Stewart ME. The blind leading the blind: use and misuse of blinding in randomized controlled trials.. Contemp Clin Trials 2011 Mar;32(2):240-3.
    doi: 10.1016/j.cct.2010.11.004pubmed: 21070890google scholar: lookup

Citations

This article has been cited 6 times.
  1. Carmona JU, López C. Platelet-Rich Plasma in Equine Osteoarthritis: A Systematic Review of Clinical and Experimental Evidence. Animals (Basel) 2025 Sep 9;15(18).
    doi: 10.3390/ani15182647pubmed: 41007891google scholar: lookup
  2. Luque RM, Henderson B, McCorkell TC, Alizadeh AH, Russell KA, Koch TG, Koenig J. Treatment outcomes for equine osteoarthritis with mesenchymal stromal cells and hyaluronic acid. Equine Vet J 2025 Sep;57(5):1245-1254.
    doi: 10.1111/evj.14531pubmed: 40364589google scholar: lookup
  3. Guerra-Gomes M, Ferreira-Baptista C, Barros J, Alves-Pimenta S, Gomes P, Colaço B. Exploring the Potential of Non-Cellular Orthobiologic Products in Regenerative Therapies for Stifle Joint Diseases in Companion Animals. Animals (Basel) 2025 Feb 18;15(4).
    doi: 10.3390/ani15040589pubmed: 40003071google scholar: lookup
  4. Carmona JU, Carmona-Ramírez LH, López C. Platelet-Rich Plasma and Related Orthobiologics for the Treatment of Equine Musculoskeletal Disorders-A Bibliometric Analysis from 2000 to 2024. Vet Sci 2024 Aug 21;11(8).
    doi: 10.3390/vetsci11080385pubmed: 39195839google scholar: lookup
  5. Wu J, Huang S, Yu Y, Lian Q, Liu Y, Dai W, Liu Q, Pan Y, Liu GA, Li K, Liu C, Li G. Human adipose and synovial-derived MSCs synergistically attenuate osteoarthritis by promoting chondrocyte autophagy through FoxO1 signaling. Stem Cell Res Ther 2024 Aug 15;15(1):261.
    doi: 10.1186/s13287-024-03870-6pubmed: 39148121google scholar: lookup
  6. Pérez Fraile A, González-Cubero E, Martínez-Flórez S, Olivera ER, Villar-Suárez V. Regenerative Medicine Applied to Musculoskeletal Diseases in Equines: A Systematic Review. Vet Sci 2023 Nov 23;10(12).
    doi: 10.3390/vetsci10120666pubmed: 38133217google scholar: lookup
Subscribe to our newsletter
Join 99,780 horse owners like you who receive our email updates on horse health and nutrition.